1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Prostate Cancer Nuclear Medicine Diagnostics Market – By Type

1.3.2        North America Prostate Cancer Nuclear Medicine Diagnostics Market – By PET Product

1.3.3        North America Prostate Cancer Nuclear Medicine Diagnostics Market – By End User

1.3.4        North America Prostate Cancer Nuclear Medicine Diagnostics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Prostate Cancer Nuclear Medicine Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        North America PEST Analysis

4.3         Experts Opinion

5.           North America Prostate Cancer Nuclear Medicine Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Prostate Cancer

5.1.2        Surging Demand for Early and Precise Diagnosis of Prostate Cancer

5.2         Market Restraints

5.2.1        High Cost Related to the Prostate Cancer Diagnostics and Treatment

5.3         Market Opportunities

5.3.1        Growing Use of Radiopharmaceuticals in Prostate Cancer

5.4         Future Trends

5.4.1        Increasing Research Activities for Development of Innovative Imaging Agents

5.5         Impact Analysis

6.           Prostate Cancer Nuclear Medicine Diagnostics Market– North America Analysis

6.1         North America Prostate Cancer Nuclear Medicine Diagnostics Market Revenue Forecast and Analysis

7.           North America Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By Type

7.1         Overview

7.2         North America Prostate Cancer Nuclear Medicine Diagnostics Market, By Type, 2022 & 2028 (%)

7.3         SPECT

7.3.1        Overview

7.3.2        SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

7.4         PET

7.4.1        Overview

7.4.2        PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

8.           North America Prostate Cancer Nuclear Medicine Diagnostics Market Analysis – By PET Product

8.1         Overview

8.2         North America Prostate Cancer Nuclear Medicine Diagnostics Market, By PET Product, 2022 & 2028 (%)

8.3         F-18

8.3.1        Overview

8.3.2        F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         C-11

8.4.1        Overview

8.4.2        C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.5         GA 68 PSMA

8.5.1        Overview

8.5.2        GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Prostate Cancer Nuclear Medicine Diagnostics Market – By End User

9.1         Overview

9.2         North America Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User- 2022 & 2028 (%)

9.3         Hospitals

9.3.1        Overview

9.3.2        Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Clinics

9.4.1        Overview

9.4.2        Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Prostate Cancer Nuclear Medicine Diagnostics Market – By Country Analysis

10.1      North America: Prostate Cancer Nuclear Medicine Diagnostics Market

10.1.1     Overview

10.1.2     North America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)

10.1.2.1       US: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.1.1       Overview

10.1.2.1.2       US: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.1.3       US: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.2.1.4       US: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)

10.1.2.1.5       US: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)

10.1.2.2       Canada: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.2.1       Overview

10.1.2.2.2       Canada: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.2.3       Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.2.2.4       Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)

10.1.2.2.5       Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)

10.1.2.3       Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.3.1       Overview

10.1.2.3.2       Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.2.3.3       Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.2.3.4       Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product, 2019–2028 (US$ ‘Million)

10.1.2.3.5       Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User, 2019–2028 (US$ ‘Million)

11.        Prostate Cancer Nuclear Medicine Diagnostics Market–Industry Landscape

11.1      Overview

11.2      Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028

11.3      Inorganic Growth Strategies

11.3.1     Overview

11.4      Organic Growth Strategies

11.4.1     Overview

12.        Company Profiles

12.1      Blue Earth Diagnostics Limited

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      ImaginAb

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Curium

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Jubilant Radiopharma

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      NCM-USA LLC

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      ABX advanced biochemical compounds GmbH

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Telix Pharmaceuticals Ltd.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Novartis AG

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Theragnostics

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   Lantheus Medical Imaging, Inc.

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             US: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.             US: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 3.             US: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 4.             Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.             Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.             Canada: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.             Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.             Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, PET Product – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.             Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.          Recent Inorganic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market

Table 11.          Recent Organic Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market

Table 12.          Glossary of Terms, Prostate Cancer Nuclear Medicine Diagnostics Market

LIST OF FIGURES

Figure 1.           North America Prostate Cancer Nuclear Medicine Diagnostics Market Segmentation

Figure 2.           North America Prostate Cancer Nuclear Medicine Diagnostics Market, By Country

Figure 3.           North America Prostate Cancer Nuclear Medicine Diagnostics Market Overview

Figure 4.           PET Segment Held Largest Share of Type Segment in Prostate Cancer Nuclear Medicine Diagnostics Market

Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           North America Experts Opinion

Figure 8.           North America Prostate Cancer Nuclear Medicine Diagnostics Market Impact Analysis of Drivers and Restraints

Figure 9.           North America Prostate Cancer Nuclear Medicine Diagnostics Market– Revenue Forecast and Analysis – 2022 - 2028

Figure 10.        North America Prostate Cancer Nuclear Medicine Diagnostics Market, by Type, 2022 & 2028 (%)

Figure 11.        North America SPECT: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        North America PET: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        North America Prostate Cancer Nuclear Medicine Diagnostics Market, by PET Product, 2022 & 2028 (%)

Figure 14.        North America F-18: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 15.        North America C-11: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16.        North America GA 68 PSMA: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        North America Prostate Cancer Nuclear Medicine Diagnostics Market Share by End User - 2022 & 2028 (%)

Figure 18.        North America Hospitals: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        North America Clinics: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        North America Others: Prostate Cancer Nuclear Medicine Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        North America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Key Country – Revenue (2022) (US$ ‘Million)

Figure 22.        North America: Prostate Cancer Nuclear Medicine Diagnostics Market, by Country, 2022 & 2028 (%)

Figure 23.        US: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 24.        Canada: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 25.        Mexico: Prostate Cancer Nuclear Medicine Diagnostics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 26.        Growth Strategies in the Prostate Cancer Nuclear Medicine Diagnostics Market, 2021-2028